RDFN News
Archived Headlines
- US IPO Weekly Recap: Brokerage Redfin and biotech Sienna soar, RBB bancorp flat 07/28/17
- Redfin prices IPO at $15, above the range 07/27/17
- US IPO Week Ahead: A real estate brokerage, a bank and a biotech 07/21/17
- Surreal estate: Online real estate company Redfin sets terms for $120 million IPO 07/17/17
- US IPO Week Ahead: Two health care companies scheduled for a slow week 07/07/17
See more
Renaissance Capital's 3Q17 US IPO Market Review
IPO Market Enters Fourth Quarter with the Wind at its Back The US IPO market saw 29 IPOs raise $4.1 billion in the third quarter, a drop from the prior year period. Small-cap health care companies, mostly biotechs, made up almost half of all...read more
US IPO Week Ahead: The Post-Labor Day Pick-Up
There are no IPOs scheduled to price in the shortened holiday week. Although August has been particularly slow with just five deals this month, filings have accelerated with eleven deals joining the pipeline this week. ...read more
US IPO Week Ahead: No IPOs during eclipse week, but keep an eye out for filings
There are no IPOs expected to price in the week ahead. To date, six IPOs have raised a combined $1.1 billion this month, the lowest number since 2011, when four IPOs raised $937 million. Although ...read more
US IPO Weekly Recap: Two IPOs start off the annual August lull
Two IPOs raised a combined $574 million this past week and notched modest gains. Pigments supplier Venator Materials raised $454 million and ultra-rare bone disease biotech Clementia Pharmaceuticals raised $120 million. July 2017 was the ...read more